Literature DB >> 17969944

Interleukin-6 receptor antagonist as therapy for rheumatoid arthritis.

Monica Crawford, Larry Moreland.   

Abstract

Entities:  

Year:  2007        PMID： 17969944

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  4 in total

Review 1.  Medical therapy: where are we now?

Authors:  Beth H Resman-Targoff
Journal:  Am J Health Syst Pharm       Date:  2006-09-15       Impact factor: 2.637

2.  A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions.

Authors:  Annette H M van der Helm-van Mil; Saskia le Cessie; Henrike van Dongen; Ferdinand C Breedveld; René E M Toes; Tom W J Huizinga
Journal:  Arthritis Rheum       Date:  2007-02

3.  Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.

Authors:  Norihiro Nishimoto; Jun Hashimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Norikazu Murata; Désirée van der Heijde; Tadamitsu Kishimoto
Journal:  Ann Rheum Dis       Date:  2007-05-07       Impact factor: 19.103

4.  Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

Authors:  Norihiro Nishimoto; Kazuyuki Yoshizaki; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Jun Hashimoto; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Arthritis Rheum       Date:  2004-06
  4 in total
  1 in total

Review 1.  Recent advances in neutralizing the IL-6 pathway in arthritis.

Authors:  Charles J Malemud
Journal:  Open Access Rheumatol       Date:  2009-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.